ArticleJournal of cancer research and clinical oncology2017

Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells.

Jihao Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.